Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 403 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Normal Weight Clear all

Conditions: Breast Cancer
Interventions: 12 month exercise and weight loss intervention; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 21 Years to 69 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Healthy
Interventions: High calorie diet, Fasting; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma, Obesity
Interventions: Pioglitazone, Placebo; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years to 60 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Colchester, Vermont

Conditions: Obesity
Interventions: Semaglutide Injectable Product (not provided by the study); Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Breast Cancer, Obesity
Interventions: Game intervention, Standard intervention; Behavioral
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Healthy
Interventions: Fasting; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 45 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Insulin Sensitivity, Muscle Weakness, Adiposity, Insulin Resistance
Interventions: Diet Weight Loss; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Rheumatoid Arthritis, Inflammation, Obesity, Ketogenic Dieting, Metabolic Syndrome
Interventions: Ketogenic diet; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Adult Anaplastic (Malignant) Meningioma, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Brain Stem Glioma, Adult Choroid Plexus Neoplasm, Adult Diffuse Astrocytoma, Adult Ependymoblastoma, Adult Ependymoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Grade II Meningioma, Adult Medulloblastoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Papillary Meningioma, Adult Pineal Gland Astrocytoma, Adult Pineoblastoma, Adult Primary Melanocytic Lesion of Meninges, Adult Supratentorial Primitive Neuroectodermal Tumor, Malignant Adult Intracranial Hemangiopericytoma, Metastatic Malignant Neoplasm in the Brain, Multiple Sclerosis, Recurrent Adult Brain Neoplasm
Interventions: Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Gadobenate Dimeglumine, Gadobutrol, Gadopentetate Dimeglumine; Procedure · Drug · Radiation
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Rheumatoid Arthritis, Healthy
Interventions: Etanercept; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity
Interventions: Cold exposure, Exposure to thermoneutral conditions; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obese, Normal Body Weight, Prediabetes, Metabolic Syndrome
Interventions: Fat biopsy, Propranolol and fat biopsy, heavy water and fat biopsy; Procedure · Drug · Other
Lead sponsor: Philip Kern; Other
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Visceral Obesity, Insulin Resistance
Interventions: Water-only fasting; Other
Lead sponsor: TrueNorth Health Foundation; Other
Eligibility: 40 Years to 70 Years
Enrollment: 48 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: Obesity, Insulin Resistance
Interventions: Fat biopsy during scheduled abdominal surgery, Fat Aspiration, Fish Oil Supplement; Procedure · Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 50 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Healthy, Normal Weight, Overweight, Obese
Interventions: High-polyphenol olive oil, Low-polyphenol olive oil; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 20 Years to 45 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Davis, California

Conditions: Breast Cancer
Interventions: Couples-Based Behavioral Weight and Symptom Management; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hyperandrogenemia, Polycystic Ovary Syndrome, Obesity
Interventions: Dexamethasone, Cortrosyn; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 7 Years to 18 Years · Female only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Polycystic Ovary Syndrome
Interventions: Mirabegron, B Complex Plus Vitamin C Tablets; Drug · Other
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 40 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Measure Grams and Kcals of Snack Foods Consumed in Each Condition
Interventions: Healthy Foods, Unhealthy Snack Foods; Other
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Sarcoma, Bone, Sarcoma, Soft Tissue, Osteosarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft-tissue Sarcoma
Interventions: Diffusion Weighted Magnetic Resonance Imaging; Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Obesity, Disorder of Lipid Storage and Metabolism, Lipid Metabolism Disorders, Metabolic Disorder
Interventions: Exercise; Behavioral
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 18 Years to 40 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Obesity, Breast Cancer Risk
Interventions: tirzepatide; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 40 Years to 64 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Kansas City, Kansas • Westwood, Kansas

Conditions: Healthy, Obesity
Interventions: Adipose Tissue Biopsy, Exercise; Procedure · Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Rheumatoid Arthritis, Myositis, Osteoarthritis, Weakness, Muscle
Interventions: Strength Training; Other
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 18 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Shreveport, Louisiana

Search by objective public record fields.

Behavioral Weight Loss and Exercise After Treatment (BEAT)

The Effects of Acute Weight Gain and Acute Calorie Deprivation on Marrow Adipose Tissue

Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)

Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.

Self-monitoring Activity: a Randomized Trial of Game-oriented Applications

The Effect of Calorie Deprivation on Adipose Tissue Distribution

Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

Ketogenic Diet in Rheumatoid Arthritis (RA)

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept

The Role of Brown Adipose Tissue in Triglyceride Clearance in People

Cold Induced Changes in White Adipose

The Effects of Water-only Fasting and Refeeding on Body Composition

Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue

Olive Oil Polyphenols and Cardiovascular Health Biomarkers

Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partners

Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

The Effect of Watching a Television Show on the Liking of Snack Foods

Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers

A Study of Adipose Tissue in Adaptive Responses to Exercise

Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations